Dosages for treatment with anti-erbb2 antibodies

Details Dosages for treatment with anti-erbb2 antibodies Dosages for treatment with anti-erbb2 antibodies

A - Human Necessities

61

K

A61K 39/395 (2006.01) C07K 16/32 (2006.01) A61K 38/12 (2006.01)

Patent

CA 2382100

The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with anti-ErbB2 antibody.

La présente invention concerne le traitement de pathologies caractérisées par une surexpression de ErbB2. Cette invention concerne plus particulièrement le traitement avec des anticorps anti-ErbB2 de patients humains susceptibles de développer un cancer à surexpression de ErbB2, ou de patients pour lequel ce diagnostic a été établi.

Affiliated with

Also associated with

Rating

Dosages for treatment with anti-erbb2 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosages for treatment with anti-erbb2 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosages for treatment with anti-erbb2 antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1426726